arrow
C

Christine J. O'Neill

University of Newcastle
H指数:34
被引数:5,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Better outcomes for the older surgical patient trial (BOOST): protocol for a hybrid type 1 effectiveness-implementation trial of an embedded geriatric perioperative service within emergency and elective surgery in an Australian tertiary referral hospital

BOOST试验中老年外科患者更好结局:在澳大利亚三级转诊医院急诊和择期手术中嵌入老年围手术期服务的混合类型1有效性-实施试验方案

2026-05-150
PRE
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study

乳头状甲状腺癌AJCC分类的基因修饰:一项国际、多中心、回顾性队列研究

2025-09-290
PRE
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer

BRAF V600E状态可显著区分乳头状甲状腺癌的淋巴结转移相关死亡风险

2021-07-1740
OA
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma

BRAF V600E状态可能有助于对低危甲状腺乳头状微小癌进行主动监测的决策

2020-01-0139
OAAI
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
2019-02-0179
PREAI
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment

BRAF V600E突变辅助的孤立性甲状腺内乳头状甲状腺癌风险分层精准治疗

2017-11-1857
OAAI
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer

肿瘤多灶性对甲状腺乳头状癌临床预后的预测价值

2017-06-0582
OAAI
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial
2016-07-05173
OAAI
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants
2016-01-01178
OAAI
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
2013-04-10808
OA